{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:56:45Z","timestamp":1791298605927,"version":"4.1.0"},"reference-count":71,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,10,10]],"date-time":"2019-10-10T00:00:00Z","timestamp":1570665600000},"content-version":"vor","delay-in-days":2322,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thebreastonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Breast"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1016\/j.breast.2013.03.006","type":"journal-article","created":{"date-parts":[[2013,4,17]],"date-time":"2013-04-17T16:00:44Z","timestamp":1366214444000},"page":"203-210","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":75,"title":["International guidelines for management of metastatic breast cancer (MBC) from the European School of Oncology (ESO)\u2013MBC Task Force: Surveillance, staging, and evaluation of patients with early-stage and metastatic breast cancer"],"prefix":"10.1016","volume":"22","author":[{"given":"Nancy U.","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Thomssen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatima","family":"Cardoso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Cameron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanja","family":"Cufer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lesley","family":"Fallowfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prudence A.","family":"Francis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stella","family":"Kyriakides","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia","family":"Pagani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elzbieta","family":"Senkus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric P.","family":"Winer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.breast.2013.03.006_bib1","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1200\/JCO.2006.08.6876","article-title":"Surveillance testing among survivors of early-stage breast cancer","volume":"25","author":"Keating","year":"2007","journal-title":"J\u00a0Clin Oncol"},{"issue":"1","key":"10.1016\/j.breast.2013.03.006_bib2","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.breast.2006.11.002","article-title":"Metastatic breast cancer. Recommendations proposal from the European School of Oncology (ESO)-MBC Task Force","volume":"16","year":"2007","journal-title":"Breast (Edinburgh, Scotland)"},{"issue":"17","key":"10.1016\/j.breast.2013.03.006_bib3","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1093\/jnci\/djp235","article-title":"International guidelines for management of metastatic breast cancer: combination vs sequential single-agent chemotherapy","volume":"101","author":"Cardoso","year":"2009","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"7","key":"10.1016\/j.breast.2013.03.006_bib4","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1093\/jnci\/djq029","article-title":"International guidelines for management of metastatic breast cancer: can metastatic breast cancer be cured?","volume":"102","author":"Pagani","year":"2010","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"6","key":"10.1016\/j.breast.2013.03.006_bib5","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1038\/sj.bjc.6601655","article-title":"Patient's needs and preferences in routine follow-up after treatment for breast cancer","volume":"90","author":"de Bock","year":"2004","journal-title":"Br J Cancer"},{"issue":"9 Suppl.","key":"10.1016\/j.breast.2013.03.006_bib6","doi-asserted-by":"crossref","first-page":"108s","DOI":"10.1200\/JCO.2003.01.190","article-title":"Doc, shouldn't we be getting some tests?","volume":"21","author":"Loprinzi","year":"2003","journal-title":"J\u00a0Clin Oncol"},{"issue":"1","key":"10.1016\/j.breast.2013.03.006_bib7","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/00000421-199102000-00013","article-title":"Perceptions of follow-up care in women with breast cancer","volume":"14","author":"Muss","year":"1991","journal-title":"Am J Clin Oncol"},{"issue":"4","key":"10.1016\/j.breast.2013.03.006_bib8","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1200\/JCO.1997.15.4.1401","article-title":"Measuring standards of care for early breast cancer in an insured population","volume":"15","author":"Hillner","year":"1997","journal-title":"J\u00a0Clin Oncol"},{"issue":"1","key":"10.1016\/j.breast.2013.03.006_bib9","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/BF01806630","article-title":"An analysis of the cost of clinical surveillance after primary therapy for women with early stage invasive breast cancer","volume":"37","author":"Simon","year":"1996","journal-title":"Breast Cancer Res Treat"},{"issue":"4","key":"10.1016\/j.breast.2013.03.006_bib10","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1200\/JOP.200009","article-title":"Population-based longitudinal study of follow-up care for breast cancer survivors","volume":"6","author":"Grunfeld","year":"2010","journal-title":"J\u00a0Oncol Pract\/Am Soc Clin Oncol"},{"issue":"8","key":"10.1016\/j.breast.2013.03.006_bib11","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1200\/JCO.2000.18.8.1718","article-title":"Economic impact of harmonizing medical practices: compliance with clinical practice guidelines in the follow-up of breast cancer in a French Comprehensive Cancer Center","volume":"18","author":"Mille","year":"2000","journal-title":"J\u00a0Clin Oncol"},{"issue":"3","key":"10.1016\/j.breast.2013.03.006_bib12","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s10549-005-5199-2","article-title":"Follow-up cost of breast cancer patients with localized disease after primary treatment: a randomized trial","volume":"93","author":"Kokko","year":"2005","journal-title":"Breast Cancer Res Treat"},{"issue":"Suppl. 2","key":"10.1016\/j.breast.2013.03.006_bib13","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1093\/annonc\/6.suppl_2.S61","article-title":"Economic evaluation of diagnostic follow-up after primary treatment for breast cancer. Results of the Working Group on Economic-Organizational Aspects of Follow-up","volume":"6","author":"Mapelli","year":"1995","journal-title":"Ann Oncol"},{"issue":"2","key":"10.1016\/j.breast.2013.03.006_bib14","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/BF01806207","article-title":"Clinical surveillance for early stage breast cancer: an analysis of claims data","volume":"40","author":"Simon","year":"1996","journal-title":"Breast Cancer Res Treat"},{"issue":"7","key":"10.1016\/j.breast.2013.03.006_bib15","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1200\/JCO.2005.01.079","article-title":"Weight, weight gain, and survival after breast cancer diagnosis","volume":"23","author":"Kroenke","year":"2005","journal-title":"J\u00a0Clin Oncol"},{"issue":"3","key":"10.1016\/j.breast.2013.03.006_bib16","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1001\/jama.298.3.289","article-title":"Influence of a diet very high in vegetables, fruit, and fiber and low in fat on prognosis following treatment for breast cancer: the Women's Healthy Eating and Living (WHEL) randomized trial","volume":"298","author":"Pierce","year":"2007","journal-title":"J\u00a0Am Med Assoc"},{"issue":"12","key":"10.1016\/j.breast.2013.03.006_bib17","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1200\/JCO.2000.18.12.2406","article-title":"Second malignancies after treatment of early-stage breast cancer: lumpectomy and radiation therapy versus mastectomy","volume":"18","author":"Obedian","year":"2000","journal-title":"J\u00a0Clin Oncol"},{"issue":"5","key":"10.1016\/j.breast.2013.03.006_bib18","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.ejca.2010.11.006","article-title":"The value of routine physical examination in the follow up of women with a history of early breast cancer","volume":"47","author":"Lu","year":"2011","journal-title":"Eur J Cancer"},{"issue":"8","key":"10.1016\/j.breast.2013.03.006_bib19","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1001\/jama.2011.188","article-title":"Accuracy and outcomes of screening mammography in women with a personal history of early-stage breast cancer","volume":"305","author":"Houssami","year":"2011","journal-title":"J\u00a0Am Med Assoc"},{"issue":"19","key":"10.1016\/j.breast.2013.03.006_bib20","doi-asserted-by":"crossref","first-page":"4010","DOI":"10.1200\/JCO.2004.06.080","article-title":"Effectiveness of routine visits and routine tests in detecting isolated locoregional recurrences after treatment for early-stage invasive breast cancer: a meta-analysis and systematic review","volume":"22","author":"de Bock","year":"2004","journal-title":"J\u00a0Clin Oncol"},{"issue":"3","key":"10.1016\/j.breast.2013.03.006_bib21","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s10549-008-0023-4","article-title":"Impact on survival of early detection of isolated breast recurrences after the primary treatment for breast cancer: a meta-analysis","volume":"114","author":"Lu","year":"2009","journal-title":"Breast Cancer Res Treat"},{"issue":"12","key":"10.1016\/j.breast.2013.03.006_bib22","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1038\/sj.bjc.6604065","article-title":"Follow-up in breast cancer: does routine clinical examination improve outcome? A systematic review of the literature","volume":"97","author":"Montgomery","year":"2007","journal-title":"Br J Cancer"},{"key":"10.1016\/j.breast.2013.03.006_bib23","article-title":"Detection of local recurrence following breast-conserving treatment in young women with early breast cancer: optimization of long-term follow-up strategies","author":"van der Sangen","year":"2012","journal-title":"Breast (Edinburgh, Scotland)"},{"issue":"17","key":"10.1016\/j.breast.2013.03.006_bib24","doi-asserted-by":"crossref","first-page":"3000","DOI":"10.1016\/j.ejca.2009.08.007","article-title":"The value of surveillance mammography of the contralateral breast in patients with a history of breast cancer","volume":"45","author":"Lu","year":"2009","journal-title":"Eur J Cancer"},{"issue":"2","key":"10.1016\/j.breast.2013.03.006_bib25","first-page":"75","article-title":"American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography","volume":"57","author":"Saslow","year":"2007","journal-title":"CA Cancer J Clin"},{"issue":"20","key":"10.1016\/j.breast.2013.03.006_bib26","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1001\/jama.1994.03510440053032","article-title":"Intensive diagnostic follow-up after treatment of primary breast cancer. A randomized trial. National Research Council Project on Breast Cancer follow-up","volume":"271","author":"Rosselli Del Turco","year":"1994","journal-title":"J\u00a0Am Med Assoc"},{"issue":"17","key":"10.1016\/j.breast.2013.03.006_bib27","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1001\/jama.281.17.1586","article-title":"Intensive vs clinical follow-up after treatment of primary breast cancer: 10-year update of a randomized trial. National Research Council Project on Breast Cancer follow-up","volume":"281","author":"Palli","year":"1999","journal-title":"J\u00a0Am Med Assoc"},{"issue":"20","key":"10.1016\/j.breast.2013.03.006_bib28","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1001\/jama.1994.03510440047031","article-title":"Impact of follow-up testing on survival and health-related quality of life in breast cancer patients. A multicenter randomized controlled trial. The GIVIO Investigators","volume":"271","author":"GIVIO","year":"1994","journal-title":"J\u00a0Am Med Assoc"},{"issue":"1","key":"10.1016\/j.breast.2013.03.006_bib29","article-title":"Follow-up strategies for women treated for early breast cancer","author":"Rojas","year":"2005","journal-title":"Cochrane Database Syst Rev (Online)"},{"issue":"2","key":"10.1016\/j.breast.2013.03.006_bib30","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/bjs.1800760227","article-title":"Follow-up after treatment of primary breast cancer","volume":"76","author":"Rutgers","year":"1989","journal-title":"Br J Surg"},{"issue":"1","key":"10.1016\/j.breast.2013.03.006_bib31","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1002\/1097-0142(19850101)55:1<202::AID-CNCR2820550132>3.0.CO;2-X","article-title":"A\u00a0retrospective study of earliest indicators of recurrence in patients on Eastern Cooperative Oncology Group adjuvant chemotherapy trials for breast cancer. A preliminary report","volume":"55","author":"Pandya","year":"1985","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.breast.2013.03.006_bib32","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1007\/BF02303645","article-title":"Evaluation of an intensive strategy for follow-up and surveillance of primary breast cancer","volume":"5","author":"Joseph","year":"1998","journal-title":"Ann Surg Oncol"},{"issue":"5C","key":"10.1016\/j.breast.2013.03.006_bib33","first-page":"4485","article-title":"Long-term follow-up study in breast cancer patients using serum tumor markers CEA and CA 15-3","volume":"19","author":"Lumachi","year":"1999","journal-title":"Anticancer Res"},{"issue":"24","key":"10.1016\/j.breast.2013.03.006_bib34","doi-asserted-by":"crossref","first-page":"13761","DOI":"10.1073\/pnas.2235592100","article-title":"Cancer risks attributable to low doses of ionizing radiation: assessing what we really know","volume":"100","author":"Brenner","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"10.1016\/j.breast.2013.03.006_bib35","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1148\/radiol.2323031095","article-title":"Estimated radiation risks potentially associated with full-body CT screening","volume":"232","author":"Brenner","year":"2004","journal-title":"Radiology"},{"issue":"9","key":"10.1016\/j.breast.2013.03.006_bib36","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/S0959-8049(01)00429-4","article-title":"Ca 15-3 in the follow-up of localised breast cancer: a prospective study","volume":"38","author":"Kokko","year":"2002","journal-title":"Eur J Cancer"},{"issue":"6","key":"10.1016\/j.breast.2013.03.006_bib37","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1200\/JCO.1997.15.6.2322","article-title":"Use of Truquant BR radioimmunoassay for early detection of breast cancer recurrence in patients with stage II and stage III disease","volume":"15","author":"Chan","year":"1997","journal-title":"J\u00a0Clin Oncol"},{"issue":"5","key":"10.1016\/j.breast.2013.03.006_bib38","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1002\/cncr.22867","article-title":"The impact of new chemotherapeutic and hormone agents on survival in a population-based cohort of women with metastatic breast cancer","volume":"110","author":"Chia","year":"2007","journal-title":"Cancer"},{"issue":"31","key":"10.1016\/j.breast.2013.03.006_bib39","doi-asserted-by":"crossref","first-page":"5091","DOI":"10.1200\/JCO.2006.08.8575","article-title":"American Society of Clinical Oncology 2006 update of the breast cancer follow-up and management guidelines in the adjuvant setting","volume":"24","author":"Khatcheressian","year":"2006","journal-title":"J\u00a0Clin Oncol"},{"issue":"Suppl. 4","key":"10.1016\/j.breast.2013.03.006_bib40","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1093\/annonc\/mdp114","article-title":"Primary breast cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up","volume":"20","author":"Kataja","year":"2009","journal-title":"Ann Oncol"},{"issue":"21","key":"10.1016\/j.breast.2013.03.006_bib41","doi-asserted-by":"crossref","first-page":"4042","DOI":"10.1200\/JCO.2003.08.017","article-title":"American Society of Clinical Oncology 2003 update on the role of bisphosphonates and bone health issues in women with breast cancer","volume":"21","author":"Hillner","year":"2003","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.breast.2013.03.006_bib42","series-title":"NCCN clinical practice guidlines in oncology","year":"2013"},{"issue":"14","key":"10.1016\/j.breast.2013.03.006_bib43","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1200\/JCO.2012.42.8375","article-title":"American society of clinical oncology identifies five key opportunities to improve care and reduce costs: the top five list for oncology","volume":"30","author":"Schnipper","year":"2012","journal-title":"J\u00a0Clin Oncol"},{"issue":"1","key":"10.1016\/j.breast.2013.03.006_bib44","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/cncr.11859","article-title":"Is breast cancer survival improving?","volume":"100","author":"Giordano","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.breast.2013.03.006_bib45","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/annonc\/mdq160","article-title":"Clinical practice guidelines: locally recurrent or metastatic breast cancer: ESMO clinical practice guidlines for diagnosis, treatment, and follow-up","volume":"21","author":"Cardoso","year":"2010","journal-title":"Ann Oncol"},{"issue":"4","key":"10.1016\/j.breast.2013.03.006_bib46","first-page":"299","article-title":"AGO Recommendations for diagnosis and treatment of patients with primary and metastatic breast cancer","volume":"6","author":"Thomssen","year":"2011","journal-title":"Update 2011. Breast Care (Basel)"},{"issue":"33","key":"10.1016\/j.breast.2013.03.006_bib47","doi-asserted-by":"crossref","first-page":"5287","DOI":"10.1200\/JCO.2007.14.2364","article-title":"American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer","volume":"25","author":"Harris","year":"2007","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.breast.2013.03.006_bib48","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.breast.2012.03.003","article-title":"1st International consensus guidelines for advanced breast cancer (ABC 1)","volume":"21","author":"Cardoso","year":"2012","journal-title":"Breast (Edinburgh, Scotland)"},{"issue":"1","key":"10.1016\/j.breast.2013.03.006_bib49","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s11912-010-0137-9","article-title":"The need to examine metastatic tissue at the time of progression of breast cancer: is re-biopsy a necessity or a luxury?","volume":"13","author":"Khasraw","year":"2011","journal-title":"Curr Oncol Rep"},{"issue":"6","key":"10.1016\/j.breast.2013.03.006_bib50","doi-asserted-by":"crossref","first-page":"R92","DOI":"10.1186\/bcr2771","article-title":"Prospective comparison of switches in biomarker status between primary and recurrent breast cancer: the Breast Recurrence In Tissues Study (BRITS)","volume":"12","author":"Thompson","year":"2010","journal-title":"Breast Cancer Res"},{"issue":"1","key":"10.1016\/j.breast.2013.03.006_bib51","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0959-8049(98)00354-2","volume":"35","author":"Andersson","year":"1999","journal-title":"Eur J Cancer"},{"issue":"2","key":"10.1016\/j.breast.2013.03.006_bib52","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur J Cancer"},{"issue":"6","key":"10.1016\/j.breast.2013.03.006_bib53","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.2214\/ajr.176.6.1761433","article-title":"Breast cancer: assessing the use of routine pelvic CT in patient evaluation","volume":"176","author":"Drotman","year":"2001","journal-title":"Am J Roentgenol"},{"issue":"2","key":"10.1016\/j.breast.2013.03.006_bib54","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1093\/annonc\/mdq343","article-title":"Positron emission tomography\/computed tomography in the management of recurrent\/metastatic breast cancer: a large retrospective study from the Royal Marsden Hospital","volume":"22","author":"Constantinidou","year":"2011","journal-title":"Ann Oncol"},{"issue":"18","key":"10.1016\/j.breast.2013.03.006_bib55","first-page":"iii","article-title":"An economic evaluation of positron emission tomography (PET) and positron emission tomography\/computed tomography (PET\/CT) for the diagnosis of breast cancer recurrence","volume":"15","author":"Auguste","year":"2011","journal-title":"Health Technol Assess (Winchester, England)"},{"issue":"7","key":"10.1016\/j.breast.2013.03.006_bib56","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1093\/annonc\/mdn057","article-title":"Comparison between positron emission tomography using 2-[fluorine-18]fluoro-2-deoxy-d-glucose, conventional imaging and computed tomography for staging of breast cancer","volume":"19","author":"Mahner","year":"2008","journal-title":"Ann Oncol"},{"issue":"3","key":"10.1016\/j.breast.2013.03.006_bib57","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s10549-008-9953-0","article-title":"PET-based estradiol challenge as a predictive biomarker of response to endocrine therapy in women with estrogen-receptor-positive breast cancer","volume":"113","author":"Dehdashti","year":"2009","journal-title":"Breast Cancer Res Treat"},{"issue":"7","key":"10.1016\/j.breast.2013.03.006_bib58","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1001\/jama.2009.1204","article-title":"Lower-dose vs high-dose oral estradiol therapy of hormone receptor-positive, aromatase inhibitor-resistant advanced breast cancer: a phase 2 randomized study","volume":"302","author":"Ellis","year":"2009","journal-title":"J\u00a0Am Med Assoc"},{"issue":"4","key":"10.1016\/j.breast.2013.03.006_bib59","doi-asserted-by":"crossref","first-page":"275","DOI":"10.3816\/CBC.2010.n.035","article-title":"Pilot trial of preoperative (neoadjuvant) letrozole in combination with bevacizumab in postmenopausal women with newly diagnosed estrogen receptor- or progesterone receptor-positive breast cancer","volume":"10","author":"Forero-Torres","year":"2010","journal-title":"Clin Breast Cancer"},{"issue":"2","key":"10.1016\/j.breast.2013.03.006_bib60","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/RLU.0b013e31815f23b7","article-title":"Meta-analysis: comparison of F-18 fluorodeoxyglucose-positron emission tomography and bone scintigraphy in the detection of bone metastases in patients with breast cancer","volume":"33","author":"Shie","year":"2008","journal-title":"Clin Nucl Med"},{"issue":"6","key":"10.1016\/j.breast.2013.03.006_bib61","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/S1470-2045(09)70088-9","article-title":"Imaging bone metastases in breast cancer: techniques and recommendations for diagnosis","volume":"10","author":"Costelloe","year":"2009","journal-title":"Lancet Oncol"},{"issue":"8","key":"10.1016\/j.breast.2013.03.006_bib62","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.2967\/jnumed.110.076455","article-title":"18F-FDG PET\/CT findings and circulating tumor cell counts in the monitoring of systemic therapies for bone metastases from breast cancer","volume":"51","author":"De Giorgi","year":"2010","journal-title":"J\u00a0Nucl Med"},{"issue":"8","key":"10.1016\/j.breast.2013.03.006_bib63","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1056\/NEJMoa040766","article-title":"Circulating tumor cells, disease progression, and survival in metastatic breast cancer","volume":"351","author":"Cristofanilli","year":"2004","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.breast.2013.03.006_bib64","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1093\/annonc\/mdr263","article-title":"High independent prognostic and predictive value of circulating tumor cells compared with serum tumor markers in a large prospective trial in first-line chemotherapy for metastatic breast cancer patients","volume":"23","author":"Pierga","year":"2012","journal-title":"Ann Oncol"},{"issue":"31","key":"10.1016\/j.breast.2013.03.006_bib65","doi-asserted-by":"crossref","first-page":"5153","DOI":"10.1200\/JCO.2008.20.6664","article-title":"Circulating tumor cells: a useful predictor of treatment efficacy in metastatic breast cancer","volume":"27","author":"Liu","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"issue":"3","key":"10.1016\/j.breast.2013.03.006_bib66","first-page":"979","article-title":"Changing levels of circulating tumor cells in monitoring chemotherapy response in patients with metastatic breast cancer","volume":"31","author":"Hartkopf","year":"2011","journal-title":"Anticancer Res"},{"issue":"1","key":"10.1016\/j.breast.2013.03.006_bib67","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1093\/annonc\/mdq323","article-title":"Circulating tumor cells (CTCs) in metastatic breast cancer (MBC): prognosis, drug resistance and phenotypic characterization","volume":"22","author":"Gradilone","year":"2011","journal-title":"Ann Oncol"},{"issue":"10","key":"10.1016\/j.breast.2013.03.006_bib68","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1038\/sj.bjc.6605676","article-title":"Improving the yield of circulating tumour cells facilitates molecular characterisation and recognition of discordant HER2 amplification in breast cancer","volume":"102","author":"Flores","year":"2010","journal-title":"Br J Cancer"},{"issue":"11","key":"10.1016\/j.breast.2013.03.006_bib69","doi-asserted-by":"crossref","first-page":"3600","DOI":"10.1158\/1078-0432.CCR-11-0255","article-title":"mRNA and microRNA expression profiles in circulating tumor cells and primary tumors of metastatic breast cancer patients","volume":"17","author":"Sieuwerts","year":"2011","journal-title":"Clin Cancer Res"},{"issue":"5","key":"10.1016\/j.breast.2013.03.006_bib70","doi-asserted-by":"crossref","first-page":"392","DOI":"10.3816\/CBC.2010.n.052","article-title":"Changes of HER2 status in circulating tumor cells compared with the primary tumor during treatment for advanced breast cancer","volume":"10","author":"Munzone","year":"2010","journal-title":"Clin Breast Cancer"},{"issue":"9","key":"10.1016\/j.breast.2013.03.006_bib71","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/S1548-5315(11)70415-6","article-title":"Living with metastatic breast cancer: a global patient survey","volume":"7","author":"Mayer","year":"2010","journal-title":"Community Oncol"}],"container-title":["The Breast"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960977613000623?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960977613000623?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T08:29:17Z","timestamp":1760776157000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960977613000623"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":71,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["S0960977613000623"],"URL":"https:\/\/doi.org\/10.1016\/j.breast.2013.03.006","relation":{},"ISSN":["0960-9776"],"issn-type":[{"value":"0960-9776","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"International guidelines for management of metastatic breast cancer (MBC) from the European School of Oncology (ESO)\u2013MBC Task Force: Surveillance, staging, and evaluation of patients with early-stage and metastatic breast cancer","name":"articletitle","label":"Article Title"},{"value":"The Breast","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.breast.2013.03.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}